Literature DB >> 22045403

Prognostic assessment in patients with hepatic encephalopathy.

Rita García-Martínez1, Macarena Simón-Talero, Juan Córdoba.   

Abstract

Hepatic encephalopathy (HE) is a common complication of liver failure that is associated with poor prognosis. However, the prognosis is not uniform and depends on the underlying liver disease. Acute liver failure is an uncommon cause of HE that carries bad prognosis but is potentially reversible. There are several prognostic systems that have been specifically developed for selecting patients for liver transplantation. In patients with cirrhosis the prognosis of the episode of HE is usually dictated by the underlying precipitating factor. Acute-on-chronic liver failure is the most severe form of decompensation of cirrhosis, the prognosis depends on the number of associated organ failures. Patients with cirrhosis that have experienced an episode of HE should be considered candidates for liver transplant. The selection depends on the underlying liver function assessed by the Model for End-stage Liver Disease (MELD) index. There is a subgroup that exhibits low MELD and recurrent HE, usually due to the coexistence of large portosystemic shunts. The recurrence of HE is more common in patients that develop progressive deterioration of liver function and hyponatremia. The bouts of HE may cause sequels that have been shown to persist after liver transplant.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22045403      PMCID: PMC3826802          DOI: 10.3233/DMA-2011-0840

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  6 in total

Review 1.  Portosystemic shunt syndrome and endovascular management of hepatic encephalopathy.

Authors:  Wael E Saad
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

2.  Non-HFE iron overload as a surrogate marker of disease severity in patients of liver cirrhosis.

Authors:  Mohd Talha Noor; Manish Tiwari; Ravindra Kumar
Journal:  Indian J Gastroenterol       Date:  2016-02-13

Review 3.  Evidence-based approach to management of hepatic encephalopathy in adults.

Authors:  Gilles Jadd Hoilat; Fathima Keshia Suhail; Talal Adhami; Savio John
Journal:  World J Hepatol       Date:  2022-04-27

4.  Primary prophylaxis of hepatic encephalopathy in decompensated cirrhosis: Low dose vs. full dose rifaximin.

Authors:  Shahid Sarwar; Bushra Muhyuddin; Abdul Aleem; Muhammad Arif Nadeem
Journal:  Pak J Med Sci       Date:  2019 Sep-Oct       Impact factor: 1.088

Review 5.  Update on the Therapeutic Management of Hepatic Encephalopathy.

Authors:  Linda Skibsted Kornerup; Lise Lotte Gluud; Hendrik Vilstrup; Gitte Dam
Journal:  Curr Gastroenterol Rep       Date:  2018-04-11

6.  Differences in complications between hepatitis B-related cirrhosis and alcohol-related cirrhosis.

Authors:  Yu-Pei Zhuang; Si-Qi Wang; Zhao-Yu Pan; Hao-Jie Zhong; Xing-Xiang He
Journal:  Open Med (Wars)       Date:  2021-12-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.